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We showed in a former study (Trojani et al., 1987) that
immunohistochemical stainings on paraffin-embedded
sections improved the detection of micrometastases in
axillary lymph nodes and the prediction of recurrence and
survival in invasive ductal carcinoma (IDC). The invasive
lobular carcinoma (ILC) sample was considered too small to
determine the prognostic value of micrometastases in this
group. In this study, we have reviewed 91 cases of ILC in
which axillary lymph nodes were free of metastases (average
follow-up 6.5 years). The purpose was to determine first the
increase in the detection rate of micrometastases by immuno-
histochemical procedure, and secondly the prognostic
significance of these micrometastases.
A series of 102 consecutive patients operated on for
primary invasive lobular carcinoma (ILC) of the breast
between 1965 and 1977 were selected for study (N-, MO). All
slides of tumours and lymph nodes were reviewed to assess
histologic tumour type and to ensure no occult metastasis
had escaped our notice. Sixteen cases were excluded, 8
because micrometastases were detected at this second
examination, and 8 because the carcinoma was not lobular
in type. Thus, 86 cases were included in this study. They
were treated by Patey mastectomy (73 cases) or by the
combination of conservative surgery and radiation therapy
(13 cases). All patients had an axillary node dissection. Eight
of them had a contralateral lobular carcinoma: treatment
was by axillary dissection in 5 of the cases which were
invasive; the other 3, in situ, were not dissected. Thus 91
specimens of axillary node dissection were examined.
The mean number of lymph nodes in each case was 14
(range 2-29). The mean age of the patients was 58 years at
operation (range 35-80 years). The average time of follow-up
from surgery to the end of the study was 6.5 years and 45%
of these patients fell into a 6-15 year period. Tumour size
was distributed as follows: To: 3, T1:24, T2:48, T3: 4, TX: 7.
There was associated lobular carcinoma in situ in 63 cases
(73%).
The number of recurrences was 8/86 (9%), 5 between
0 and 5 years, 3 between 5 and 10 years. There was no
statistically significant difference in the recurrence rate
between T1 or T2 patients (T1: 1/24, T2 2/48). The number
of patients who died from their cancer was 4 (2 between
0 and 5 years; 1 at 7 years and 1 at 12 years), and 5 died of
other causes.
As in our former study, the slides used were the original
H&E sections (Voigt et al., 1986), stained by a three stage
immunoperoxidase procedure (Delsol et al., 1984) with anti-
cytokeratin (KLI Immunotech, France) as monoclonal
antibody.
The statistical significance of differences in proportions
was studied by contingency tables and chi-square test. The
Kaplan and Meier method was used in calculating recurrence
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and survival curves. The logrank test was used to examine
the statistical significance of observed differences. An
observation was considered to be statistically significant if
P<0.05.
Frequency of micrometastases detected by immunohisto-
chemistry In 37/91 specimens of axillary node dissection
(41%), micrometastases were unequivocally detected either in
one (26%), two (6%), three (6%), or four (3%) lymph
nodes.
In all cases, these micrometastases were composed of
single cells situated either in the subcapsular sinuses or
among lymphocytes.
Prognostic influence of the micrometastases The clinical
course was studied by two variables, recurrence rate and
survival including only patients who had died from the
cancer. No correlation was found between the presence of
micrometastases and recurrence or survival rate (Figures 1
and 2).
An increase in the immunohistochemical detection of
micrometastases to axillary lymph nodes from breast
carcinoma has been found in several studies including
carcinomas of all histologic types. These metastases were
more frequent in ILC than in IDC. Wells et al. (1984)
studied 45 cases of invasive carcinoma (12 ILC and 33 IDC)
and found 33% micrometastases in ILC compared to 9% in
IDC. In our former study (Trojani et al., 1987), we found
38% in 21 ILC compared to 11% in 122 IDC. Bussolati et
al. (1986) studied a series of 50 cases of ILC and found 24%
micrometastases of which 10% were visible on H&E
sections from serial sectioning. The mean follow-up was 3.5
years with a range from 2 to 7 years, not quite sufficient to
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Figure 1 Micrometastases and recurrence rate in the ILC group.
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determine the prognostic value of immunohistochemical
staining in detecting micrometastases. However, at the time
of reporting the data, the positive cases showed neither an
increased recurrence rate nor a shortened survival time.
The present study is the first to include a large number of
node dissections of ILC and to demonstrate that no
significant relationshipexistsbetweenmicrometastases detected
by immunohistochemical techniques and recurrent disease or
survival.
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Figure 2 Micrometastases and survival of patients in the ILC group.
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